Published in Semin Liver Dis on January 01, 2004
Viral hepatitis in HIV infection. N Engl J Med (2007) 4.18
Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy. BMC Infect Dis (2015) 1.44
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol (2012) 1.24
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials. PLoS One (2012) 1.19
Hepatitis B virus S gene escape mutants. Asian J Transfus Sci (2007) 1.14
Chronic hepatitis B: A wave of new therapies on the horizon. Antiviral Res (2015) 0.99
HBV life cycle: entry and morphogenesis. Viruses (2009) 0.98
Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1. J Virol (2013) 0.98
Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen. J Virol (2010) 0.97
Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha. J Virol (2008) 0.90
Atypical serological profiles in hepatitis B virus infection. Eur J Clin Microbiol Infect Dis (2012) 0.88
Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus. J Clin Microbiol (2008) 0.85
Clinical characteristics and current management of hepatitis B and C in China. World J Gastroenterol (2014) 0.84
The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile". Eur J Clin Microbiol Infect Dis (2011) 0.84
Hepatitis B virus pre-S2 start codon mutations in Indonesian liver disease patients. World J Gastroenterol (2012) 0.82
Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma. PLoS One (2014) 0.82
Peroxisome proliferator-activated receptors in HBV-related infection. PPAR Res (2009) 0.82
Clonal evolution of hepatitis B virus polymerase gene mutations during lamivudine-adefovir combination treatment. World J Gastroenterol (2012) 0.81
Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells. J Biol Chem (2014) 0.80
Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestine. PLoS One (2014) 0.79
Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens. World J Gastroenterol (2006) 0.79
Molecular epidemiological study on pre-X region of hepatitis B virus and identification of hepatocyte proteins interacting with whole-X protein by yeast two-hybrid. World J Gastroenterol (2005) 0.78
LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing enhancer II/basal core promoter activity. Sci Rep (2016) 0.77
Association between TNFAIP3 nonsynonymous single-nucleotide polymorphism rs2230926 and chronic hepatitis B virus infection in a Chinese Han population. Virol J (2015) 0.77
Molecular characterization of hepatitis B virus X gene in chronic hepatitis B patients. Virol J (2012) 0.77
Exploitation of host clock gene machinery by hepatitis viruses B and C. World J Gastroenterol (2013) 0.77
Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression. PLoS One (2013) 0.77
The Role of Interferon in Hepatitis B Therapy. Curr Hepat Rep (2010) 0.76
Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection. Clin Exp Med (2012) 0.76
Kupffer Cell Metabolism and Function. J Enzymol Metab (2015) 0.75
Bioinformatic Identification of Rare Codon Clusters (RCCs) in HBV Genome and Evaluation of RCCs in Proteins Structure of Hepatitis B Virus. Hepat Mon (2016) 0.75
Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity. PLoS One (2017) 0.75
Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria. Afr Health Sci (2015) 0.75
Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection. Iran J Basic Med Sci (2016) 0.75
The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation. PLoS One (2015) 0.75
Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo. PLoS One (2017) 0.75
Hepatitis viruses exploitation of host DNA methyltransferases functions. Clin Exp Med (2015) 0.75
New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection. Gastroenterol Hepatol (N Y) (2017) 0.75